Terminated PHASE4 INTERVENTIONAL 2-arm NCT01921829

Protocolized Diuretic Strategy in Cardiorenal Failure (ProDiuS)

Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial

Sponsor: Kelly V. Liang, MD

Conditions Cardiac Failure Kidney Failure Renal Failure

Interventions Protocolized Diuretic Strategy

Updated 7 times since 2017 Last updated: Jul 18, 2017 Started: Nov 30, 2013 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to futility due to lower than expected recruitment

Listed as NCT01921829, this PHASE4 trial focuses on Cardiac Failure and Kidney Failure and remains terminated or withdrawn. Sponsored by Kelly V. Liang, MD, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Aug 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Aug 2017 [monthly]

Terminated PHASE4

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kelly V. Liang, MD

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States